Transdermal fentanyl as treatment for chronic low back pain

Journal of Pain and Symptom Management

Volumn 14, Issue 4, 1997, Pages 218-224

  Simpson Jr , Richard K ^a   Edmondson, Everton A ^a   Constant, Charles F ^a   Collier, Connie ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic low back pain; Transcutaneous fentanyl patch

Indexed keywords

FENTANYL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOW BACK PAIN; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; SCORING SYSTEM; TITRIMETRY; VERTIGO;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANALGESICS, OPIOID; CHRONIC DISEASE; FEMALE; FENTANYL; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED;

EID: 0342872057     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(97)00183-8     Document Type: Article

References (23)

1. Waddell G. Low back disability: a syndrome of western civilization. Neurosurg Clin North Am 1991;2:719-738.
2. Loeser JD, Volinn EL. Epidemiology of low back pain. Neurosurg Clin North Am 1991;2:713-718.
3. Long DM. Failed back surgery syndrome. Neurosurg Clin North Am 1991;2:899-919.
4. Butler SH. Pharmacologic treatment of low back pain. Neurosurg Clin North Am 1991;2:891-897.
5. Deyo RA. Nonsurgical care of low back pain. Neurosurg Clin North Am 1991;2:851-862.
6. Rosomoff HI, Rosomoff RS. Comprehenisve multidisciplinary pain center approach to the treatment of low back pain. Neurosurg Clin North Am 1991;2:877-890.
7. Donner B, Zenz M. Transdermal fentanyl: a new step on the therapeutic ladder. Anti-Cancer Drugs 1995;3(suppl 6):39-43.
8. Lehmann KA, Zech D. Transdermal fentanyl: clinical pharmacology. J Pain Symptom Manage 1992;7(suppl 3):S8-16.
9. Slover R. Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center. J Pain Symptom Manage 1992;7(suppl 3):S45-47.
10. Calis KA, Kohler DR, Corso DM. Transdermally administered fentanyl for pain management. Clin Pharm 1992;11:22-36.
11. Herbst LH, Strause LC. Transdermal fentanyl use in hospice home-care patients with chronic cancer pain. J Pain Symptom Manage 1992;7(suppl 3):S54-57.
12. Levy MH, Rosen SM, Kedziera P. Transdermal fentanyl: seeding trial in patients with chronic cancer pain. J Pain Symptom Manage 1992;7(suppl 3):S48-50.
13. Skaer TL. Management of pain in the cancer patient. Clin Ther 1993;15:638-649.
14. Portenoy RK, Southam MA, Gupta SK, Lapin J, Layman M, Inturrisi CE. Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology 1993;78:36-43.
15. Simmonds MA. Transdermal fentanyl: clinical development in the United States. Anti-Cancer Drugs 1995;3(suppl 6):35-38.
16. Southam MA. Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy. Anti-Cancer Drugs 1995;3(suppl 6):29-34.
17. Payne R. Transdermal fentanyl: suggested recommendations for clinical use. J Pain Symptom Manage 1992;7(suppl 3):S40-44.
18. Payne R, Chandler S, Einhaus M. Guideline for the clinical use of transdermal fentanyl Anti-Cancer Drugs 1995;3(suppl 6):50-53.
19. Moulin DE, Iezzi A, Rasheed A, Sharpe WKJ, Boyd D, Merksey H. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347:143-147.
20. Portenoy RK. Chronic opioid therapy in non malignant pain. J Pain Symptom Manage 1990; 5(suppl 1):S46-62.
21. Zenz M, Strumpg M, Tryba M. Long-term oral opioid therapy with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:68-77.
22. Gronblad M, Upi M, Wennerstrand P, et al. Intercorrelation and test-retest reliability of the pain disability index (PDI) and the Oswestry disability questionnaire (ODQ) and their correlation with pain intensity in low back pain patients. Clin J Pain 1993;9:189-195.
23. Snyder-Halpern R, Verran JA. Instrumentation to describe subjective sleep characteristics in healthy subjects. Res Nurs Health 1987;10:155-163.